Bioconversion of Ginsenoside RB1 into compound K by Leuconostoc citreum LH1 isolated from kimchi

Brazilian Journal of Microbiology

Volumn 42, Issue 3, 2011, Pages 1227-1237

  Quan, Lin Hu ^a   Piao, Jin Ying ^a   Min, Jin Woo ^a   Yang, Dong Uk ^a   Lee, Hee Nyeong ^a   Yang, Deok Chun ^a  

^a Kyung Hee University   (South Korea)

Author keywords

Bioconversion; Compound K; Ginsenoside RB1; Leuconostoc citreum LH1

Indexed keywords

EID: 83455230662     PISSN: 15178382     EISSN: 16784405     Source Type: Journal    
DOI: 10.1590/S1517-83822011000300049     Document Type: Article

References (35)

1. Bae, E.A.; Han, M.J.; Choo, M.K.; Park, S.Y.; Kim, D.H. (2002). Metabolism of 20(S)-and 20(R)-ginsenoside Rg3 by human intestinal bacteria and its relation to in vitro biological activities. Biol. Pharm. Bull.25, 58-63.
2. Bae, E.A.; Kim, N.Y.; Han, M.J.; Choo, M.K.; Kim, D.H. (2003). Transformation of ginsenoside to compound k (IH-901) by Lactic acid bacteria of human intestine. J. Microbiol. Biotechnol. 13(1), 9-14.
3. Bae, E.A.; Park, S.Y.; Kim, D.H. (2000). Constitutive β-glucosidases hydrolyzing ginsenoside Rb1 and Rb2 from human intestinal bacteria. Biol. Pharm. Bull. 23, 1481-1485.
4. Benishin, C.G. (1992). Action of ginsenoside Rb1 on choline uptake in central cholinergic nerve endings. Neurochem. Int. 21(1), 1-5.
5. Brekhman, I.I. (1976). Ancient ginseng and pharmacology. In: Proc. Symp. Gerontology, Lugano, Switzerland. p. 6.
6. Cheng, L.Q.; Kim, M.K.; Lee, J.W.; Yang, D.C. (2006). Conversion of major ginsenoside Rb1 to ginsenoside F2 by Caulobacter leidyia. Biotechnol. Lett. 28, 1121-1127.
7. Dong, A.; Ye, M.; Guo, H.; Zheng, J.; Guo, D. (2003). Microbial transformation of ginsenoside Rb1 by Rhizopus stolonifer and Curvularia lunata. Biotechnol Lett. 25, 339-344.
8. Dou, d.; Wen, Y.; Pei, Y.; Chen, Y.; Ma, Z. (1997). Active constituents reducing side-effects of prednisone acetate in leaves of Panax ginseng C.A.Mey. zhongguo. zhong yao. za zi. 22(3), 174-176.
9. Han, B.H.; Park, M.H.; Han, Y.N.; Woo, L.K.; Sankawa, U.; Yahara, S.; Tanaka, O. (1982). Degradation of ginseng saponins under mild acidic conditions. Planta. Med. 44, 146-149.
10. Huo, Y.; Chen, Y. (1998). The effect of Panax ginseng extract(GS) on insulin and corticosteroid receptors. J. Traditional Chinese Medicine. 8(4), 293-295.
11. Kang, S.Y.; Kim, N.D. (1992). The antihypertensive effect of red ginseng saponin and the endothelium-derived vascular relaxtion. Korean. J. Ginseng Sci. 18, 175-182.
12. Karikura, M.; Miyase, T.; Tanizawa, H.; Taniyama, T.; Takino, Y. (1991). Studies on absorption, distribution, excretion and metabolism of ginseng sa1ponins. VI. The decomposition products of ginsenoside Rb2 in the stomach of rats. Chem. Pharm. Bull. 39(2), 400-404.
13. Kikuchi, Y.; Sasa, H.; Kita, T.; Hirata, J.; Tode, T. (1991). Inhibition of human ovarian cancer cell proliferation in vitro by ginsenoside-Rh2 and adjuvant effects of cisplatin in vivo. Anticancer. Drugs. 2(1), 63-67.
14. Kim, H.Y.; Chen, X.; Gillis, C.N. (1992). Ginsenosides protect pulmonary vascular endothelium against free radical induced injury. Biochem. Biophys. Res. Comm. 189(2), 670-676.
15. Kim, S.D.; Seu, J.H. (1989). Enzymatic properties of the convertible enzyme of ginseng saponin produced from Rhizopus japonicus. Kor. J. App. Microbiol. Bioeng. 17(2), 126-130.
16. Ko, S.R.; Choi, K.J.; Uchida, K.; Suzuki, Y. (2003). Enzymatic preparation of ginsenosides Rg2, Rh1, and F1 from protopanaxatrioltype ginseng saponin mixture. Planta. Med.69, 285-286.
17. Mei, B.; Wang, Y.E.; Wu, JX.; Chen, W.Z. (1994). Protective effect of ginsenosides on oxygen free radical induced damages of cultured vascular endothelial cells in vitro. Yao. Hsueh Hsuuh Pao. 29(11), 801-808.
18. Ogita, S.; Samugawa, K. (1994). Clinical effectiveness of Korea ginseng on patients with climacteric disturbances. The Ginseng Review. 18, 95-97.
19. Oura, H.; Hiai, S. (1973). Physiological chemistry of ginseng. Metabolism. Disease. 10, 564-569.
20. Park, S.Y.; Bae, E.A.; Sung, J.H.; Lee, S.K.; Kim, D.H. (2001). Purification and characterization of ginsenoside Rb1-metabolizing β-glucosidase from Fusobacterium K-60, a huma intestinal anaerobic bacterium. Biosci. Biotechnol. Biochem. 65(5), 1163-1169.
21. Saito, H.; Bao, T.T. (1984). Effect of red ginseng on mice exposed to various stress. In: Proc. 4th Int'l. Ginseng Symp. Seoul, Korea. p.97-105.
22. Saito, H.; Nishiyama, N. (1988). Effect of ginseng and its saponins on experimental amnesis in mice and on cell cultures of neurons. In: Proc. 5th Int'l. Ginseng Symp. Seoul, Korea. p.92-98.
23. Sano, K.; Amemura, A.; Harada, T. (1975). Purification and properties of a beta-1,6-clucosidase from Flavobacterium. Biochim. Biophys. Acta. 377(2), 410-420.
24. Shibata, S.; Tanaka, O.; Soma, K.; Iita, Y.; Ando, T.; Nakamura, H. (1965). Studis on saponins and sapogenens of ginseng: the structure of panaxatriol. Tetrahedron. Letters. 3, 207-213.
25. Shin, J.E.; Park, E.K.; Kim, E.J.; Hong, Y.H.; Lee, K.T.; Kim, D.H. (2003). Cytotoxicity of compound K (IH-901) and ginsenoside Rh2, main biotransformants of ginseng saponins by Bifidobacteria, against Some Tumor Cells. Ginseng. Res. 27, 129-134.
26. Singh, V.K.; Agarwal, S.S.; Gupta, B.M. (1984). Immunomodulatory activity of panax ginseng extract. In: Proc. 4th Int'l. Ginseng Symp. Seoul, Korea. p.225-232.
27. Sung, J.H.; Hideo, H.; Satoshi, M.; Masamori, U. (1995). Metabolism of ginseng saponins by intestinal Bacteria. Kor. J. Pharmacogn. 26, 360-367.
28. Takino, Y. (1994). Studies on the pharmacodynamics of ginsenoside-Rg1, -Rb1 and -Rb2 in rats. Yakugaku. Zasshi. 114(8), 550-564.
29. Tanizawa, H.; Karikuma, M.; Miyase, T.; Takono, Y. (1993). Studies on the metabolism and/or decomposition and distribution of ginsenoside Rb2 in rats. In: Proc. 6th Int. Ginseng Symp. Seoul. p.187-194.
30. Tawab, M.A.; Bahr, U.; Karas, M.; Wurglics, M.; Schubert, Z.M. (2003). Degradation of ginsenosides in humans after oral administration. Drug. Metab. Dispos. 31, 1065-1071.
31. Wang, B.X.; Cui, J.C.; Liu, A.J.; Wu, S.K. (1983). Studies on the anti-fatigue effect of the saponins of stems and leaves of Panax ginseng (SSLG). J. Tradit. Chin. Med. 3(2), 89-94.
32. Xu, Q.F.; Fang, X.L.; Chen, D.F. (2003). Pharmacokinetics and bioavailability of ginsenoside Rb1 and Rg1 from Panax notoginseng in rats. J. Ethnopharmacol. 84(2-3), 187-192.
33. Yoshioka, H.; Hayashida, S. (1980). Purification and properties of β-glucosidase from Humicola insolens YH-8. Agr. Biol. Chem. 44, 1729-1735.
34. Zhang, D.; Liu, Y.P.; Yu, H.S.; Jin, F.X.; Chen, G.X. (2003). Purification of ginsenoside β-glucosidase hydrolase and its characteristics. Ying Yong Yu Huan Jing Sheng Wu Xue Bao. 9(3), 259-262.
35. Zhou, W.; Feng, M.Q.; Li, J.Y.; Zhou, P. (2006). Studies on the preparation, crystal structure and bioactivity of ginsenoside compound K. Journal of Asian Natural Products Research. 8(6), 519-527.